Mauna Kea Technologies SA

1MK

Company Profile

  • Business description

    Mauna Kea Technologies SA is a medical device company that develops, manufactures and markets an imaging platform for visualizing tissue at the cellular level, in real time, during standard procedures, with the mission of eliminating uncertainties in diagnosis and treatment through direct visualization of tissue in vivo at the microscopic level. The company’s flagship product, Cellvizio, is the smallest microscope, designed for direct use during minimally invasive procedures. It operates in a single business segment: endomicroscopy. Its geographical presence includes EMEA (Europe, Middle East, Africa), USA and Canada, and Asia with the majority of the revenue deriving from USA and Canada.

  • Contact

    9 rue d'Enghien
    Paris75010
    FRA

    T: +33 148240345

    https://www.maunakeatech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    53

Stocks News & Analysis

stocks

ASX healthcare giant remains well positioned despite share slump

We welcome the CEO change at CSL but relatively soft plasma performance will postpone recovery
stocks

Australian bank remains overvalued despite strong result

When strong fundamentals meet persistent valuation headwinds.
stocks

Chart of the Week: Soft earnings growth outlook for Australian banks

The latest take from our equity research analysts.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,281.8041.30-0.44%
CAC 408,402.1388.891.07%
DAX 4025,168.25312.101.26%
Dow JONES (US)50,331.83210.430.42%
FTSE 10010,463.848.27-0.08%
HKSE27,032.54233.84-0.86%
NASDAQ23,003.8862.59-0.27%
Nikkei 22557,639.8410.70-0.02%
NZX 50 Index13,531.4824.200.18%
S&P 5006,948.286.810.10%
S&P/ASX 2009,043.5018.50-0.20%
SSE Composite Index4,134.022.030.05%

Market Movers